Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy.

Wataru GotoShinichiro KashiwagiYuka AsanoKoji TakadaKatsuyuki TakahashiTakaharu HatanoTsutomu TakashimaShuhei TomitaHisashi MotomuraMasahiko OhsawaKosei HirakawaMasaichi Ohira

Published in: ESMO open (2018)

Improvement in the iTME following NAC is correlated with good outcome. The rate of change in the CFR may be a useful biomarker to predict prognosis of patients treated with NAC.

Keyphrases

neoadjuvant chemotherapy
transcription factor
locally advanced
lymph node
sentinel lymph node
genome wide analysis
rectal cancer
squamous cell carcinoma
early stage